NCT00001565View on ClinicalTrials.gov

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

December 31, 1996

Study Completion Date

October 31, 2000

Conditions

Brain NeoplasmsNeuroblastoma

Interventions

DRUG

phenylbutyrate

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH